1-methyl-1-[2-(4-methyl-1H-benzimidazol-2-yl)ethyl]-3-[(1R)-1-(4-propan-2-yl-1,2,4-triazol-3-yl)ethyl]urea
C19H27N7O — CID 125436916
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-methyl-1-[2-(4-methyl-1H-benzimidazol-2-yl)ethyl]-3-[(1R)-1-(4-propan-2-yl-1,2,4-triazol-3-yl)ethyl]urea
1-methyl-1-[2-(4-methyl-1H-benzimidazol-2-yl)ethyl]-3-[(1R)-1-(4-propan-2-yl-1,2,4-triazol-3-yl)ethyl]urea (PubChem CID 125436916) has the molecular formula C19H27N7O and a molecular weight of 369.47 g/mol. Its IUPAC name is 1-methyl-1-[2-(4-methyl-1H-benzimidazol-2-yl)ethyl]-3-[(1R)-1-(4-propan-2-yl-1,2,4-triazol-3-yl)ethyl]urea.
Molecular Properties
| Compound Name | 1-methyl-1-[2-(4-methyl-1H-benzimidazol-2-yl)ethyl]-3-[(1R)-1-(4-propan-2-yl-1,2,4-triazol-3-yl)ethyl]urea |
|---|---|
| PubChem CID | 125436916 |
| Molecular Formula | C19H27N7O |
| Molecular Weight | 369.47 g/mol |
| Exact Mass | 369.23 |
| IUPAC Name | 1-methyl-1-[2-(4-methyl-1H-benzimidazol-2-yl)ethyl]-3-[(1R)-1-(4-propan-2-yl-1,2,4-triazol-3-yl)ethyl]urea |
| SMILES | Cc1cccc2[nH]c(CCN(C)C(=O)N[C@H](C)c3nncn3C(C)C)nc12 |
| InChI | InChI=1S/C19H27N7O/c1-12(2)26-11-20-24-18(26)14(4)21-19(27)25(5)10-9-16-22-15-8-6-7-13(3)17(15)23-16/h6-8,11-12,14H,9-10H2,1-5H3,(H,21,27)(H,22,23)/t14-/m1/s1 |
| InChIKey | NUGDGEJBZKAKRF-CQSZACIVSA-N |
| XLogP | 2.99 |
| TPSA | 91.73 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 369.47 |
| LogP ≤ 5 | 2.99 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 125436916 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.